SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-19-002459
Filing Date
2019-04-22
Accepted
2019-04-22 16:21:00
Documents
8
Period of Report
2019-06-04
Effectiveness Date
2019-04-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2238549zdef14a.htm DEF 14A 945056
2 G343783.JPG g343783.jpg GRAPHIC 14486
3 G611863.JPG g611863.jpg GRAPHIC 51045
4 G321174.JPG g321174.jpg GRAPHIC 65579
5 G800050.JPG g800050.jpg GRAPHIC 28328
6 G324331.JPG g324331.jpg GRAPHIC 23482
7 G25892BII001.GIF g25892bii001.gif GRAPHIC 145631
8 G25892BII002.GIF g25892bii002.gif GRAPHIC 86501
  Complete submission text file 0001047469-19-002459.txt   1518863
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35060 | Film No.: 19759629
SIC: 2834 Pharmaceutical Preparations